desoxycorticosterone acetate has been researched along with rb 150 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Balavoine, F; Flahault, A; Hmazzou, R; Llorens-Cortes, C; Marc, Y | 1 |
| De Mota, N; Flahault, A; Gerbier, R; Hmazzou, R; Llorens-Cortes, C; Marc, Y | 1 |
| Balavoine, F; De Mota, N; Hmazzou, R; Llorens-Cortes, C; Marc, Y | 1 |
3 other study(ies) available for desoxycorticosterone acetate and rb 150
| Article | Year |
|---|---|
Central antihypertensive effects of chronic treatment with RB150: an orally active aminopeptidase A inhibitor in deoxycorticosterone acetate-salt rats.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Arginine Vasopressin; Blood Pressure; Brain; Desoxycorticosterone Acetate; Disulfides; Enzyme Inhibitors; Glutamyl Aminopeptidase; Hypertension; Male; Natriuresis; Rats; Sulfonic Acids | 2018 |
Brain ACE2 activation following brain aminopeptidase A blockade by firibastat in salt-dependent hypertension.
Topics: Angiotensin III; Angiotensin-Converting Enzyme 2; Animals; Antihypertensive Agents; Brain; Desoxycorticosterone Acetate; Disease Models, Animal; Disulfides; Glutamyl Aminopeptidase; Hypertension; Male; Mice; Rats, Wistar; Sodium Chloride, Dietary; Sulfonic Acids | 2021 |
Effects of firibastat in combination with enalapril and hydrochlorothiazide on blood pressure and vasopressin release in hypertensive DOCA-salt rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Desoxycorticosterone Acetate; Disease Models, Animal; Disulfides; Enalapril; Glutamyl Aminopeptidase; Hydrochlorothiazide; Hypertension; Male; Rats; Rats, Inbred WKY; Renin-Angiotensin System; Sulfonic Acids; Vasopressins | 2021 |